• Subscribe
  • Magazine
  • Past Issues
  • Surveys
  • Industry Statistics
  • About Us
  • Members Only
  • Best Places to Work
    • Recent Quotes
    My Watchlist
    Indicators
    PennEnergy Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Reshape Lifesciences Inc (NQ: RSLS )

    0.2128 +0.0028 (+1.33%)
    Streaming Delayed Price Updated: 3:58 PM EDT, Jul 23, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 402,640
    Open 0.2000
    Bid (Size) 0.2240 (10)
    Ask (Size) 0.2274 (1)
    Prev. Close 0.2100
    Today's Range 0.2025 - 0.2162
    52wk Range 0.1414 - 1.660
    Shares Outstanding 6,166,554
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CHUY, RSLS on Behalf of Shareholders
    From Halper Sadeh LLC
    Via GlobeNewswire
    RESHAPE LIFESCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of ReShape Lifesciences Inc. - RSLS
    From Kahn Swick & Foti, LLC
    Via Business Wire

    Performance

    YTD
    -20.24%
    -20.24%
    1 Month
    +7.20%
    +7.20%
    3 Month
    +27.50%
    +27.50%
    6 Month
    -4.79%
    -4.79%
    1 Year
    -84.47%
    -84.47%

    More News

    Read More
    RSLS Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of ReShape Lifesciences Inc. Is Fair to Shareholders
    From Halper Sadeh LLC
    Via Business Wire
    Why Is Reshape Lifesciences (RSLS) Stock Up 80% Today?
    Via InvestorPlace
    Why Helen of Troy Shares Are Trading Lower By Around 30%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Via Benzinga
    ReShape Lifesciences® Enters Into Merger Agreement With Vyome Therapeutics and Asset Purchase Agreement With Biorad Medisys
    From ReShape Lifesciences Inc
    Via GlobeNewswire
    12 Health Care Stocks Moving In Thursday's Intraday Session
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's After-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's Intraday Session
    Via Benzinga
    S&P 500 Down 0.5%; Abercrombie & Fitch Earnings Top Views
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Why Bank of Montreal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Intraday Session
    Via Benzinga
    Crude Oil Moves Lower; Advance Auto Parts Shares Fall After Q1 Results
    Via Benzinga
    Exposures Fossil Fuels
    Why ReShape Lifesciences Stock Is Moving Higher Wednesday
    Via Benzinga
    Topics Intellectual Property
    Exposures Intellectual Property
    Dow Dips Over 300 Points; Dick's Sporting Goods Posts Upbeat Earnings
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Why Is Cue Health (HLTH) Stock Down 40% Today?
    Via InvestorPlace
    Topics Bankruptcy
    Exposures Financial Legal
    Why Is Faraday Future (FFIE) Stock Down 32% Today?
    Via InvestorPlace
    Why Is Banzai International (BNZI) Stock Up 25% Today?
    Via InvestorPlace
    Why Ooma Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session
    Via Benzinga
    Amid Ozempic's 'Miracle' Weight-Loss Craze, This Company Peaked Over 100% In Tuesday Pre-Market After Receiving Approval For Obesity Treatment
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
    Via InvestorPlace
    12 Health Care Stocks Moving In Tuesday's After-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Friday's After-Market Session
    Via Benzinga
    RSLS Stock Earnings: Reshape Lifesciences Beats EPS, Misses Revenue for Q1 2024
    Via InvestorPlace
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.